Search

Lenora R Bigler

age ~60

from Clinton, MS

Also known as:
  • Lenora Bigler
  • Lenora Garrett
15 Chatham Pl, Clinton, MS 390566019249204

Lenora Bigler Phones & Addresses

  • 15 Chatham Pl, Clinton, MS 39056 • 6019249204
  • 108 Lake Forest Ln, Clinton, MS 39056
  • Chicago, IL
  • 1220 Dardanelle Dr #1A, Jackson, MS 39204 • 6019249204
  • Seattle, WA
  • 15 Chatham Pl, Clinton, MS 39056 • 6015400249

Work

  • Position:
    Transportation and Material Moving Occupations

Education

  • Degree:
    Associate degree or higher

Emails

Us Patents

  • Method Of Diagnosing And Monitoring Malignant Breast Carcinomas

    view source
  • US Patent:
    6670141, Dec 30, 2003
  • Filed:
    Sep 25, 2001
  • Appl. No.:
    09/962477
  • Inventors:
    Charles F. Streckfus - Brandon MS
    Lenora G. Bigler - Clinton MS
    James Tate Thigpen - Jackson MS
  • Assignee:
    University of Mississippi Medical Center - Jackson MS
  • International Classification:
    G01N 33574
  • US Classification:
    435 723, 435 4, 435 71, 435 72, 435 721, 435 792, 435 793, 435 794, 435 795, 436501, 436 63, 436 64
  • Abstract:
    A panel of biomarkers for the diagnosis and treatment of breast cancer was examined in the saliva of a cohort of 1) healthy women, 2) women with benign lesions of the breast and 3) women with diagnosed breast cancer. Recognized tumor markers c-erbB-2 (erb), cancer antigen 15-3 (CA 15-3), and tumor suppresser oncogene protein 53 (p53) were found in the saliva of all three groups of women. The levels of erb and CA 15-3 in the cancer patients evaluated, however, were significantly higher than the salivary levels of healthy controls and benign tumor patients. Conversely, pantropic p53 levels were higher in controls as compared to those women with breast cancer and those with benign tumors.
  • Method Of Diagnosing And Monitoring Malignant Breast Carcinomas

    view source
  • US Patent:
    6972180, Dec 6, 2005
  • Filed:
    Mar 1, 2000
  • Appl. No.:
    09/914501
  • Inventors:
    Charles F. Streckfus - Brandon MS,
    Lenora G. Bigler - Clinton MS,
    James Tate Thigpen - Jackson MS,
  • Assignee:
    The University of Mississippi Medical Center - Jackson MS
  • International Classification:
    G01N033/574
    G01N033/53
    G01N033/68
  • US Classification:
    435 723, 435 4, 435 71, 435 72, 435 721, 435 792, 435 793, 435 794, 436501, 436 63, 436 64
  • Abstract:
    A panel of biomarkers for the diagnosis and treatment of breast cancer was examined in the saliva of a cohort of 1) healthy women, 2) women with benign lesions of the breast and 3) women with diagnosed breast cancer. Recognized tumor markers c-erbB-2 (erb), cancer antigen 15-3 (CA 15-3), and tumor suppresser oncogene protein 53 (p53) were found in the saliva of all three groups of women. The levels of erb and CA 15-3 in the cancer patients evaluated, however, were significantly higher than the salivary levels of healthy controls and benign tumor patients. Conversely, pantropic p53 levels were higher in controls as compared to those women with breast cancer and those with benign tumors.
  • Method Of Diagnosing And Monitoring Malignant Breast Carcinomas

    view source
  • US Patent:
    62943499, Sep 25, 2001
  • Filed:
    Mar 1, 1999
  • Appl. No.:
    9/259993
  • Inventors:
    Charles F. Streckfus - Brandon MS
    Lenora G. Bigler - Clinton MS
    James Tate Thigpen - Jackson MS
  • Assignee:
    University of Mississippi Medical Ctr. - Jackson MS
  • International Classification:
    G01N 33574
    G01N 3353
    G01N 33567
    G01N 33566
    G01N 3348
  • US Classification:
    435 723
  • Abstract:
    A panel of biomarkers for the diagnosis and treatment of breast cancer was examined in the saliva of a cohort of 1) healthy women, 2) women with benign lesions of the breast and 3) women with diagnosed breast cancer. Recognized tumor markers c-erbB-2 (erb), cancer antigen 15-3 (CA 15-3), and tumor suppresser oncogene protein 53 (p53) were found in the saliva of all three groups of women. The levels of erb and CA 15-3 in the cancer patients evaluated, however, were significantly higher than the salivary levels of healthy controls and benign tumor patients. Conversely, pantropic p53 levels were higher in controls as compared to those women with breast cancer and those with benign tumors.

Get Report for Lenora R Bigler from Clinton, MS, age ~60
Control profile